News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Mikkael A. Sekeres: Top Line VERONA Results – No Advantage to AZA + VEN Compared to AZA Alone for HR-MDS
clinicaloptions.com
Jun 18, 2025, 07:42

Mikkael A. Sekeres: Top Line VERONA Results – No Advantage to AZA + VEN Compared to AZA Alone for HR-MDS

Mikkael A. Sekeres, Chief, Division of Hematology at Sylvester Comprehensive Cancer Center, shared on X:

“Wow – top line VERONA results are negative – no advantage to AZA + VEN compared to AZA alone for higher-risk MDS. AZA or DAC alone remain the standard for HR-MDS. So disappointing.”

Read Full Article.

More posts featuring Mikkael A. Sekeres.

AZA AZA + VEN cancer higher-risk MDS Mikkael A. Sekeres OncoDaily Oncology VERONA Results
Special Coverage
Blog
Jul 29, 2025, 20:21
Zouina Sarfraz: Honored to Present Our Abstract on Palliative Care at ASCOQLTY25
Blog
Jul 29, 2025, 20:19
Mieke Van Hemelrijck: Accelerating Cancer Research Through Data Standardisation
Insight
Jul 29, 2025, 20:10
Zainab Shinkafi-Bagudu: The Significant Impact of the Bone Cancer on Young Adults
Blog
Jul 29, 2025, 19:52
IU Simon Comprehensive Cancer Center seeks a Visionary Leader for Division Chief of Hematology and Oncology
Blog
Jul 29, 2025, 18:17
World Hepatitis Day: A Voice You Need to Hear - ELPA
Blog
Jul 29, 2025, 18:00
The 5th Episode of the APAC Lung Cancer Consensus Video Series - ASPIRE for Lung Cancer
Blog
Jul 29, 2025, 17:40
Prashant Chaulagain: Two of Our Abstracts Accepted for Poster Presentation at the ASCOQLTY 2025 Symposium
Blog
Jul 29, 2025, 17:38
How Collaboration Can Help Close Gaps and Improve Access to Care - ACREOL Global
Blog
Jul 29, 2025, 17:06
Working to Better Understand and Detect ALD-HCC - GENIAL-Horizon Europe
Insight
Jul 29, 2025, 15:41
Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss
Oncolibrary
Jul 29, 2025, 12:29
New Paper Alert: TUXEDO-3 Trial Demonstrates Clinical Activity of Patritumab Deruxtecan in Leptomeningeal Metastases from Solid Tumors
Insight
Jul 29, 2025, 11:49
Why Do Viruses Act So Differently? - Sbarro Health Research Organization